The Company Trying to Reprogram Aging
First. The news.
The bio-tech player New Limit has raised $130 million from just about the fanciest assembly of smart, rich people imaginable. Nat Friedman and Daniel Gross – via NFDG - Kleiner Perkins, Khosla Ventures and Human Capital are there in their corporate forms and Patrick and John Collison, Josh Kushner, Joe Lonsdale and Fred Ehrsam are there as individuals.
Over the past four years, New Limit has been trying to identify the right combinations of transcription factors – a certain class of proteins – that can rewind cells and take them back to a younger state. Their work piggybacks…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.